Treatment for a<unk>  is usually undertaken in the context of documented thrombosis, such as extremity phlebitis or dural sinus vein thrombosis. Patients with a well-documented (i.e., present at least twice)<unk>  and a history of thrombosis should be considered candidates for indefinite treatment with<unk> s. Patients with no history of thrombosis and a<unk>  should probably be observed. Current evidence suggests that the risk of recurrent thrombosis in patients with an antiphospholipid antibody is enhanced whether that antibody is measured on serological testing or functional testing. The Sapporo criteria specify that both serological and functional tests must be positive to diagnose the antiphospholipid antibody syndrome. Miscarriages may be more prevalent in patients with a<unk> . Some of these miscarriages may potentially be prevented with the administration of aspirin and unfractionated heparin. The Cochrane Database of Systematic Reviews provide a deeper understanding on the subject. Thrombosis is treated with<unk> s (LMWHs and warfarin).
Lupus anticoagulant
Β-Thromboglobulin
Von Willebrand factor
Thrombin–antithrombin complex
Thrombin
Fibrin degradation product
Fibrinogen
Factor VIII 